ClinicalTrials.gg
Sign In

Migraine Disorders clinical trials

The registry lists 1,657 studies for Migraine Disorders across more than 10 countries. 339 are recruiting or about to start. 1,426 of them are mainly about Migraine Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Migraine with Aura: 1,721 studies, 340 open.

ClinicalTrials.gov finds 1,829 studies for Migraine Disorders. How that becomes 1,657 here

This page counts the studies the registry files under Migraine Disorders, and those it files under no condition that list Migraine Disordersthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,829Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −64Filed under a narrower condition, counted on its own pageMigraine without Aura 42 · Migraine with Aura 22
  3. −79List Migraine Disorders as a condition, but the registry did not file them under itMost often written as “Chronic Migraine, Headache” (26), “Chronic Migraine” (22), and “Vestibular Migraine” (10). The registry filed them under other conditions only, most often Headache (38) and Fibromyalgia (8).
  4. −29Match it another way26 name it in the title and 3 in a keyword.
  5. 1,657The count on this page168 of them list Migraine Disorders in their own words; the registry filed them under no condition.

Get an email when these change. Save the Migraine Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
967
Recruiting
216
Status unknown
135
Not yet recruiting
97
Terminated
96
Active, not recruiting
59

Phase

Phase 3
282
Phase 2
191
Phase 4
178
Phase 1
103
Early Phase 1
10

Where

United States
696
Italy
115
Denmark
98
Spain
97
Canada
94
Turkey
92

Who runs them

Danish Headache Center (57) · Pfizer (47) · Eli Lilly and Company (33) · Allergan (29) · GlaxoSmithKline (28) · AbbVie (26) · Theranica (24) · Amgen (24)

What is being tested here

Drugs under test in Migraine Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rimegepant81426
Topiramate71544
Propranolol5411
Eptinezumab41119
Atogepant4812
Zavegepant4612
Flunarizine406
Erenumab3935
Bupivacaine3212
Lidocaine3110

Drug classes tested here CGRP receptor antagonists 19 open · Local anesthetics 6 open · Beta blockers 5 open · Calcium channel blockers 4 open · Serotonin receptor agonists 2 open

Coming up

44phase 3 studies under way
117studies finish main data collection within a year14 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 216 Migraine Disorders studies recruiting now, 65 (30%) set no upper age limit and 136 (63%) stop at 75 or younger. 44 (20%) take children under 18. 18 (8%) are for women only and 0 (0%) for men only; 36 (17%) take healthy volunteers.

Recruiting studies that take each age, of 216
AgeWomenMen
1031 (14%)30 (14%)
18182 (84%)165 (76%)
30189 (88%)171 (79%)
40189 (88%)171 (79%)
50180 (83%)170 (79%)
65155 (72%)148 (69%)
7593 (43%)87 (40%)
8572 (33%)66 (31%)

Across all 1,657 studies, recruiting or not: 67% stop at 75 or younger and 57% at 65; 15% take children; 7% are for women only and <1% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Migraine Disorders studies take

Of 140 phase 3 interventional studies under Migraine Disorders, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 16 mo2–19 · 53 studies4 mo2–12 · 39 studies—
Phase 215 mo11–30 · 73 studies12 mo7–20 · 43 studies—
Phase 2/318 mo10–23 · 12 studies——
Phase 319 mo12–40 · 140 studies18 mo11–31 · 114 studies—
Phase 427 mo17–37 · 77 studies27 mo17–33 · 28 studies29 mo18–51 · 49 studies
Interventional, no phase15 mo7–34 · 358 studies11 mo7–22 · 49 studies17 mo8–36 · 309 studies
Observational27 mo13–63 · 160 studies—27 mo13–72 · 132 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting8

Show 3 more

Results posted2

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 1,657. Browse all 1,657 → or search them.